Tuesday, July 17, 2007


Jul. 17, 2007 (M2 Communications Ltd. delivered by Newstex) --

Streetinvesting.com is the leading online financial newsletter community with thousands of investors from around the world. Our goal is to bring our theories and techniques to investors seeking a different and unique approach to investment ideas. We have a research team that has been built upon the premise of finding companies that we feel may interest investors looking for that unique and tactical edge.

Please visit www.Streetinvesting.com for the full report, additional research and related articles on the company mentioned herein.

Wall Street, still under the enchantment of takeover activities, hailed the bulls' optimism throughout the sessions of last week, but keeps a vigilant standpoint for this Monday as more second quarter earnings are due to be released. Even as the Dow Jones Industrial closed onto the 14,000 cap, stocks oscillated to the different economic reading of the day signaling that investors were excited with some big merger news and rumors and yet quite anxious of future inflation reports. The financial headlines have been flooded by a multi-billion dollar buzz throwing Vodafone and Verizon in the limelight and creating an adrenaline drive among investors. Protein Polymer Technologies Inc. (OTCBB: PPTI) closed at $ 0.18 with a trading volume of 199,766 last Friday.

Our dyed-in-the-wool research squad has been scrutinizing the Over-The-Counter Bulletin Board putting much effort in studying some of the potential companies making the news. Protein Polymer Technologies Inc. caught our attention and we decided to put them forward in an attempt to evaluate their progression in the third quarter.

On Monday July 16th, 2007, Protein Polymer Technologies Inc., a biotechnology device company that is a pioneer in protein design and synthesis, made a press release, announcing that they have entered into an agreement with a multinational biotechnology device company. According to the agreement, PPTI will provide genetically engineered protein polymer biomaterials for use in the prevention of post-surgical adhesions. 'This agreement further demonstrates our core competency; developing novel protein polymer biomaterials for challenging medical applications such as the prevention of surgical adhesions,' said William N. Plamondon, Chief Executive Officer of PPTI. 'Additionally, it furthers the progression of our plan to establish relationships with partners that will ultimately market the products. This relationship adds to the six others we have in product development which includes our license agreements with Spine Wave Inc. and Genencor International Inc.'

Post-operative adhesions, unintended attachments between distinct tissues and organs in the body, occur after most surgical procedures. Most notable are the complications that arise from adhesions after abdominal and gynecological surgery. Studies have shown that between 55% and 100% of patients developed adhesions within six months of surgery. In severe cases, adhesions can cause pain, obstructions and infertility. More than 300,000 Americans are hospitalized each year at a cost of $1.3 billion to undergo surgery to remove adhesions. PPTI believes its protein polymer materials can improve the outcome of abdominal and gynecological surgery by substantially reducing adhesions.

PPTI is also in discussions with several U.S. and international biotechnology and medical device companies, which are evaluating PPTI's surgical sealant and drug delivery product applications. These products are intended to aid in the closure of surgical incisions and tissue trauma reducing, for example, the incidence of post-operative bleeding and the delivery locally of therapeutic agents. 'We have been successful here because of the competencies we've developed in manufacturing products, supporting clinical trials, and engineering application and delivery systems that support the biomaterials platform that we own,' said Joe Cappello, Chief Technology Officer of PPTI.

Protein Polymer Technologies Inc. is a biotechnology company that discovers and develops innovative therapeutic devices to improve medical and surgical outcomes. The Company focuses on developing technology and products to be used for soft tissue augmentation, tissue adhesives and sealants, wound healing support and drug delivery devices. Protein Polymer Technologies' proprietary protein-based biomaterials are uniquely tailored to optimize clinical performance and contain no human or animal components that could potentially transmit or cause disease. The company is headquartered in San Diego, California.

With numerous essential economic data, including inflation and housing sector, due to come out throughout the course of this week, analysts predict a stimulating market sentiment that could push the bulls further into conquered territories or bring the bears back. Streetinvesting.com will stay focused on our goal to provide future news and developments on Protein Polymer Technologies Inc., as we believe some interesting events or announcements will come forth. If you wish to be where the news about Protein Polymer Technologies Inc. would smell fresh and potent, simply visit www.streetinvesting.com and access our online information log about this company freely.

Please visit www.streetinvesting.com for a complimentary subscription to access this issuance and other related in-depth articles. Please note that membership does not require credit card information nor does it require a commitment to our service.

We have initiated this news release as a tool to keep investors informed about the market. The information contained herein comes from an unbiased perspective and we do not have a vested interest in the companies mentioned in this release. Becoming a member to www.streetinvesting.com will give you access to all the on-going information and investment news that we come across.

Investors wishing to seek a different approach to their investment theories and concepts and to be informed of unique investment opportunities should also visit www.streetinvesting.com for a free membership.

About Street Investing

Streetinvesting.com has now become a leading online financial newsletter community with thousands of investors from around the world. Our goal is to bring our theories and techniques to investors seeking a different and unique approach to investment ideas. We have a research team that has been built upon the premise of finding companies that we feel may interest investors looking for that unique and tactical edge. More information can be found on our website at www.streetinvesting.com

If you have been brought here under false pretense, please let our staff know by emailing us at  support@streetinvesting.com. Please feel free to visit our site for more information and a free membership.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by Streetinvesting.com (Street Investing) based upon information believed to be reliable. The information contained herein is not guaranteed by Streetinvesting.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Streetinvesting.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Streetinvesting.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Streetinvesting.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. 'Forward-looking statements' describe future expectations, plans, results, or strategies and are generally preceded by words such as 'may', 'future', 'plan' or 'planned', 'will' or 'should', 'expected,' 'anticipates', 'draft', 'eventually' or 'projected'. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Streetinvesting.com undertakes no obligation to update such statements.

(Comments on this story may be sent to  tww.feedback@m2.com)


Newstex ID: MCOM-0001-18180714


Delivered by Newstex LLC
via theFinancials.com